Streetbeat News

Earnings

OPRX

OptimizeRx Corp (OPRX) has agreed to acquire Medicx Health for $95 million, a deal expected to close in Q4 2023. The acquisition is expected to expand OptimizeRx's footprint in life science commercial digital budgets and contribute significantly to revenue, revenue growth, EBITDA, and EPS. Post-acquisition, OptimizeRx will have approximately $12.5 million in cash and short-term equivalents. The combined company will establish relationships with approximately 300 pharmaceutical brands.

Portfolio Pulse from Vandana Singh

October 12, 2023 | 5:42 pm

ELV

A whale investor has taken a bullish stance on Elevance Health (NYSE:ELV), with 50% of investors opening trades with bullish expectations and 50% with bearish. The whale has been targeting a price range from $420.0 to $465.0 for Elevance Health over the last 3 months. Cantor Fitzgerald downgraded its action to Overweight with a price target of $547. The price of ELV is currently $453.57, with next earnings expected in 6 days.

Portfolio Pulse from Benzinga Insights

October 12, 2023 | 5:32 pm

WBA

Walgreens Boots Alliance (WBA) shares are trading higher after the company reported mixed Q4 results.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 4:24 pm

QDEL

QuidelOrtho Corporation (NASDAQ:QDEL) released preliminary Q3 revenue of $738 million to $744 million, driven by higher respiratory product sales. The company sees non-respiratory product revenue of $557 million-$560 million and respiratory product revenue of $181 million-$184 million. William Blair says respiratory product revenue is well above their estimate of $101 million. However, non-respiratory sales grew approximately 2% Y/Y to $559 million at the midpoint, missing William Blair's estimate and consensus by just over $10 million. Despite ongoing uncertainty, William Blair reaffirms an Outperform for the stock.

Portfolio Pulse from Vandana Singh

October 12, 2023 | 4:18 pm

Hecla Mining announced its Q3 production, following which its shares traded lower.

Portfolio Pulse from Benzinga Newsdesk

October 12, 2023 | 4:14 pm

BSQR

OPGN

RVLP

SECO

SLNH

TTOO

WBA

The Dow Jones index fell by more than 50 points, while the NASDAQ rose by 0.20%. Walgreens Boots Alliance Inc reported weaker-than-expected earnings for its fourth quarter, with adjusted EPS decreasing 18% to $0.67. Secoo Holding Limited, OpGen, Inc., and BSQUARE Corporation saw significant increases in their share prices, while RVL Pharmaceuticals plc, Soluna Holdings, Inc., and T2 Biosystems, Inc. experienced significant drops.

Portfolio Pulse from Lisa Levin

October 12, 2023 | 4:00 pm

Citigroup (NYSE:C) is set to release its quarterly earnings report on October 13, 2023. Analysts estimate an EPS of $1.17. Last quarter, Citigroup beat EPS estimates by $0.03, but the share price dropped by 0.0% the next day. The company's shares were trading at $41.53 as of October 11, with a 52-week return of -4.21%.

Portfolio Pulse from Benzinga Insights

October 12, 2023 | 4:00 pm

JPM

JPMorgan Chase (NYSE:JPM) is set to release its latest quarterly earnings report on October 13, 2023. Analysts estimate an earnings per share (EPS) of $3.90. The company's past performance shows it beat EPS estimates last quarter, which was followed by a 0.0% drop in share price. JPMorgan Chase's shares were trading at $146.15 as of October 11, with a 31.36% increase over the last 52-week period.

Portfolio Pulse from Benzinga Insights

October 12, 2023 | 4:00 pm

WFC

Wells Fargo (NYSE:WFC) is set to release its quarterly earnings report on Friday, 2023-10-13, with an estimated EPS of $1.22. The company's past performance shows a trend of beating EPS estimates but this has not always led to a positive impact on the share price. The stock is currently trading at $39.69, down 8.23% over the last 52-week period.

Portfolio Pulse from Benzinga Insights

October 12, 2023 | 4:00 pm

DPZ

ETWO

FAST

SRRK

VSAT

WBA

Several US stocks recorded gains in Thursday's trading session. LL Flooring surged 35% after Live Ventures proposed to acquire it for $5.85 per share. Scholar Rock surged 28.8% after pricing an upsized $85 million public offering. E2open shares gained 17.5% despite falling 50% on Wednesday due to Q2 financial results. Viasat rose 9.7% after issuing an interim update on VS-3 F1 satellite status. Cerevel Therapeutics gained 7.3% after pricing an underwritten public offering. Fastenal climbed 7% after reporting mixed Q3 financial results. Walgreens rose 4.8% after Q4 sales increased 9.2% Y/Y. Domino's Pizza gained 1.08% after reporting better-than-expected Q3 EPS results.

Portfolio Pulse from Lisa Levin

October 12, 2023 | 3:52 pm